Pre-order Enquiry
Request Free Sample
Global Oncology Precision Medicine Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17720930 | Publishing Date : 18-Mar-2021 | No. of pages : 126
Detailed TOC of Global Oncology Precision Medicine Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Oncology Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Precision Medicine Market Perspective (2016-2027)
2.2 Oncology Precision Medicine Growth Trends by Regions
2.2.1 Oncology Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Precision Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Precision Medicine Industry Dynamic
2.3.1 Oncology Precision Medicine Market Trends
2.3.2 Oncology Precision Medicine Market Drivers
2.3.3 Oncology Precision Medicine Market Challenges
2.3.4 Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2016-2021)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Precision Medicine Revenue
3.4 Global Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2020
3.5 Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Precision Medicine Breakdown Data by Type
4.1 Global Oncology Precision Medicine Historic Market Size by Type (2016-2021)
4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2022-2027)
5 Oncology Precision Medicine Breakdown Data by Application
5.1 Global Oncology Precision Medicine Historic Market Size by Application (2016-2021)
5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncology Precision Medicine Market Size (2016-2027)
6.2 North America Oncology Precision Medicine Market Size by Type
6.2.1 North America Oncology Precision Medicine Market Size by Type (2016-2021)
6.2.2 North America Oncology Precision Medicine Market Size by Type (2022-2027)
6.2.3 North America Oncology Precision Medicine Market Size by Type (2016-2027)
6.3 North America Oncology Precision Medicine Market Size by Application
6.3.1 North America Oncology Precision Medicine Market Size by Application (2016-2021)
6.3.2 North America Oncology Precision Medicine Market Size by Application (2022-2027)
6.3.3 North America Oncology Precision Medicine Market Size by Application (2016-2027)
6.4 North America Oncology Precision Medicine Market Size by Country
6.4.1 North America Oncology Precision Medicine Market Size by Country (2016-2021)
6.4.2 North America Oncology Precision Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Precision Medicine Market Size (2016-2027)
7.2 Europe Oncology Precision Medicine Market Size by Type
7.2.1 Europe Oncology Precision Medicine Market Size by Type (2016-2021)
7.2.2 Europe Oncology Precision Medicine Market Size by Type (2022-2027)
7.2.3 Europe Oncology Precision Medicine Market Size by Type (2016-2027)
7.3 Europe Oncology Precision Medicine Market Size by Application
7.3.1 Europe Oncology Precision Medicine Market Size by Application (2016-2021)
7.3.2 Europe Oncology Precision Medicine Market Size by Application (2022-2027)
7.3.3 Europe Oncology Precision Medicine Market Size by Application (2016-2027)
7.4 Europe Oncology Precision Medicine Market Size by Country
7.4.1 Europe Oncology Precision Medicine Market Size by Country (2016-2021)
7.4.2 Europe Oncology Precision Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Precision Medicine Market Size (2016-2027)
8.2 Asia-Pacific Oncology Precision Medicine Market Size by Type
8.2.1 Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Precision Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Application
8.3.1 Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Precision Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.4.1 Asia-Pacific Oncology Precision Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Precision Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Precision Medicine Market Size (2016-2027)
9.2 Latin America Oncology Precision Medicine Market Size by Type
9.2.1 Latin America Oncology Precision Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Precision Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Precision Medicine Market Size by Type (2016-2027)
9.3 Latin America Oncology Precision Medicine Market Size by Application
9.3.1 Latin America Oncology Precision Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Precision Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Precision Medicine Market Size by Application (2016-2027)
9.4 Latin America Oncology Precision Medicine Market Size by Country
9.4.1 Latin America Oncology Precision Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Precision Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Precision Medicine Market Size (2016-2027)
10.2 Middle East & Africa Oncology Precision Medicine Market Size by Type
10.2.1 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Application
10.3.1 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Precision Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.4.1 Middle East & Africa Oncology Precision Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Precision Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 Almac
11.3.1 Almac Company Details
11.3.2 Almac Business Overview
11.3.3 Almac Oncology Precision Medicine Introduction
11.3.4 Almac Revenue in Oncology Precision Medicine Business (2016-2021)
11.3.5 Almac Recent Development
11.4 ANGLE plc
11.4.1 ANGLE plc Company Details
11.4.2 ANGLE plc Business Overview
11.4.3 ANGLE plc Oncology Precision Medicine Introduction
11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2016-2021)
11.4.5 ANGLE plc Recent Development
11.5 Asuragen
11.5.1 Asuragen Company Details
11.5.2 Asuragen Business Overview
11.5.3 Asuragen Oncology Precision Medicine Introduction
11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2016-2021)
11.5.5 Asuragen Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Oncology Precision Medicine Introduction
11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2016-2021)
11.6.5 BGI Group Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction
11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BioMérieux
11.8.1 BioMérieux Company Details
11.8.2 BioMérieux Business Overview
11.8.3 BioMérieux Oncology Precision Medicine Introduction
11.8.4 BioMérieux Revenue in Oncology Precision Medicine Business (2016-2021)
11.8.5 BioMérieux Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction
11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2016-2021)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Oncology Precision Medicine Introduction
11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2016-2021)
11.10.5 Roche Holding AG Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Oncology Precision Medicine Introduction
11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Oncology Precision Medicine Introduction
11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2016-2021)
11.12.5 Illumina Recent Development
11.13 Konica Minolta
11.13.1 Konica Minolta Company Details
11.13.2 Konica Minolta Business Overview
11.13.3 Konica Minolta Oncology Precision Medicine Introduction
11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2016-2021)
11.13.5 Konica Minolta Recent Development
11.14 LabCorp
11.14.1 LabCorp Company Details
11.14.2 LabCorp Business Overview
11.14.3 LabCorp Oncology Precision Medicine Introduction
11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2016-2021)
11.14.5 LabCorp Recent Development
11.15 MDxHealth
11.15.1 MDxHealth Company Details
11.15.2 MDxHealth Business Overview
11.15.3 MDxHealth Oncology Precision Medicine Introduction
11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2016-2021)
11.15.5 MDxHealth Recent Development
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Details
11.16.2 Myriad Genetics Business Overview
11.16.3 Myriad Genetics Oncology Precision Medicine Introduction
11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2016-2021)
11.16.5 Myriad Genetics Recent Development
11.17 Novartis
11.17.1 Novartis Company Details
11.17.2 Novartis Business Overview
11.17.3 Novartis Oncology Precision Medicine Introduction
11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2016-2021)
11.17.5 Novartis Recent Development
11.18 OPKO Health
11.18.1 OPKO Health Company Details
11.18.2 OPKO Health Business Overview
11.18.3 OPKO Health Oncology Precision Medicine Introduction
11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2016-2021)
11.18.5 OPKO Health Recent Development
11.18 Pacific Biosciences
.1 Pacific Biosciences Company Details
.2 Pacific Biosciences Business Overview
.3 Pacific Biosciences Oncology Precision Medicine Introduction
.4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2016-2021)
.5 Pacific Biosciences Recent Development
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Details
11.20.2 Quest Diagnostics Business Overview
11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction
11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2016-2021)
11.20.5 Quest Diagnostics Recent Development
11.21 Qiagen
11.21.1 Qiagen Company Details
11.21.2 Qiagen Business Overview
11.21.3 Qiagen Oncology Precision Medicine Introduction
11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2016-2021)
11.21.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Oncology Precision Medicine Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Applied Sciences
Table 3. Key Players of Precision Diagnostics
Table 4. Key Players of Digital Health and Information Technology
Table 5. Key Players of Precision Therapeutics
Table 6. Global Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oncology Precision Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Oncology Precision Medicine Market Share by Regions (2016-2021)
Table 10. Global Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Oncology Precision Medicine Market Share by Regions (2022-2027)
Table 12. Oncology Precision Medicine Market Trends
Table 13. Oncology Precision Medicine Market Drivers
Table 14. Oncology Precision Medicine Market Challenges
Table 15. Oncology Precision Medicine Market Restraints
Table 16. Global Oncology Precision Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Oncology Precision Medicine Market Share by Players (2016-2021)
Table 18. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Precision Medicine as of 2020)
Table 19. Ranking of Global Top Oncology Precision Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Oncology Precision Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Precision Medicine Product Solution and Service
Table 23. Date of Enter into Oncology Precision Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Oncology Precision Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Oncology Precision Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Oncology Precision Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Oncology Precision Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Oncology Precision Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Oncology Precision Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Oncology Precision Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Oncology Precision Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Oncology Precision Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oncology Precision Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Oncology Precision Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Oncology Precision Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Oncology Precision Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Oncology Precision Medicine Product
Table 66. Abbott Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Agilent Technologies Company Details
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies Oncology Precision Medicine Product
Table 71. Agilent Technologies Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 72. Agilent Technologies Recent Development
Table 73. Almac Company Details
Table 74. Almac Business Overview
Table 75. Almac Oncology Precision Medicine Product
Table 76. Almac Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 77. Almac Recent Development
Table 78. ANGLE plc Company Details
Table 79. ANGLE plc Business Overview
Table 80. ANGLE plc Oncology Precision Medicine Product
Table 81. ANGLE plc Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 82. ANGLE plc Recent Development
Table 83. Asuragen Company Details
Table 84. Asuragen Business Overview
Table 85. Asuragen Oncology Precision Medicine Product
Table 86. Asuragen Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 87. Asuragen Recent Development
Table 88. BGI Group Company Details
Table 89. BGI Group Business Overview
Table 90. BGI Group Oncology Precision Medicine Product
Table 91. BGI Group Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 92. BGI Group Recent Development
Table 93. Bio-Rad Laboratories Company Details
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Oncology Precision Medicine Product
Table 96. Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Development
Table 98. BioMérieux Company Details
Table 99. BioMérieux Business Overview
Table 100. BioMérieux Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 101. BioMérieux Recent Development
Table 102. Bristol Myers Squibb Company Details
Table 103. Bristol Myers Squibb Business Overview
Table 104. Bristol Myers Squibb Oncology Precision Medicine Product
Table 105. Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 106. Bristol Myers Squibb Recent Development
Table 107. Roche Holding AG Company Details
Table 108. Roche Holding AG Business Overview
Table 109. Roche Holding AG Oncology Precision Medicine Product
Table 110. Roche Holding AG Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 111. Roche Holding AG Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Oncology Precision Medicine Product
Table 115. Gilead Sciences Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 116. Gilead Sciences Recent Development
Table 117. Illumina Company Details
Table 118. Illumina Business Overview
Table 119. Illumina Oncology Precision Medicine Product
Table 120. Illumina Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 121. Illumina Recent Development
Table 122. Konica Minolta Company Details
Table 123. Konica Minolta Business Overview
Table 124. Konica Minolta Oncology Precision Medicine Product
Table 125. Konica Minolta Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 126. Konica Minolta Recent Development
Table 127. LabCorp Company Details
Table 128. LabCorp Business Overview
Table 129. LabCorp Oncology Precision Medicine Product
Table 130. LabCorp Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 131. LabCorp Recent Development
Table 132. MDxHealth Company Details
Table 133. MDxHealth Business Overview
Table 134. MDxHealth Oncology Precision Medicine Product
Table 135. MDxHealth Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 136. MDxHealth Recent Development
Table 137. Myriad Genetics Company Details
Table 138. Myriad Genetics Business Overview
Table 139. Myriad Genetics Oncology Precision Medicine Product
Table 140. Myriad Genetics Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 141. Myriad Genetics Recent Development
Table 142. Novartis Company Details
Table 143. Novartis Business Overview
Table 144. Novartis Oncology Precision Medicine Product
Table 145. Novartis Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 146. Novartis Recent Development
Table 147. OPKO Health Company Details
Table 148. OPKO Health Business Overview
Table 149. OPKO Health Oncology Precision Medicine Product
Table 150. OPKO Health Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 151. OPKO Health Recent Development
Table 152. Pacific Biosciences Company Details
Table 153. Pacific Biosciences Business Overview
Table 154. Pacific Biosciences Oncology Precision Medicine Product
Table 155. Pacific Biosciences Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 156. Pacific Biosciences Recent Development
Table 157. Quest Diagnostics Company Details
Table 158. Quest Diagnostics Business Overview
Table 159. Quest Diagnostics Oncology Precision Medicine Product
Table 160. Quest Diagnostics Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 161. Quest Diagnostics Recent Development
Table 162. Qiagen Company Details
Table 163. Qiagen Business Overview
Table 164. Qiagen Oncology Precision Medicine Product
Table 165. Qiagen Revenue in Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 166. Qiagen Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Precision Medicine Market Share by Type: 2020 VS 2027
Figure 2. Applied Sciences Features
Figure 3. Precision Diagnostics Features
Figure 4. Digital Health and Information Technology Features
Figure 5. Precision Therapeutics Features
Figure 6. Global Oncology Precision Medicine Market Share by Application: 2020 VS 2027
Figure 7. Breast Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Cervical Cancer Case Studies
Figure 12. Other Cancer Case Studies
Figure 13. Oncology Precision Medicine Report Years Considered
Figure 14. Global Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Oncology Precision Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Oncology Precision Medicine Market Share by Regions: 2020 VS 2027
Figure 17. Global Oncology Precision Medicine Market Share by Regions (2022-2027)
Figure 18. Global Oncology Precision Medicine Market Share by Players in 2020
Figure 19. Global Top Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Precision Medicine as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2020
Figure 21. Global Oncology Precision Medicine Revenue Market Share by Type (2016-2021)
Figure 22. Global Oncology Precision Medicine Revenue Market Share by Type (2022-2027)
Figure 23. North America Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Oncology Precision Medicine Market Share by Type (2016-2027)
Figure 25. North America Oncology Precision Medicine Market Share by Application (2016-2027)
Figure 26. North America Oncology Precision Medicine Market Share by Country (2016-2027)
Figure 27. United States Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Oncology Precision Medicine Market Share by Type (2016-2027)
Figure 31. Europe Oncology Precision Medicine Market Share by Application (2016-2027)
Figure 32. Europe Oncology Precision Medicine Market Share by Country (2016-2027)
Figure 33. Germany Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Oncology Precision Medicine Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Oncology Precision Medicine Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Oncology Precision Medicine Market Share by Region (2016-2027)
Figure 43. China Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Oncology Precision Medicine Market Share by Type (2016-2027)
Figure 51. Latin America Oncology Precision Medicine Market Share by Application (2016-2027)
Figure 52. Latin America Oncology Precision Medicine Market Share by Country (2016-2027)
Figure 53. Mexico Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Oncology Precision Medicine Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Oncology Precision Medicine Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Oncology Precision Medicine Market Share by Country (2016-2027)
Figure 59. Turkey Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 64. Almac Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 65. ANGLE plc Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 66. Asuragen Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 67. BGI Group Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 69. BioMérieux Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 70. Bristol Myers Squibb Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 71. Roche Holding AG Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 72. Gilead Sciences Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 73. Illumina Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 74. Konica Minolta Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 75. LabCorp Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 76. MDxHealth Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 77. Myriad Genetics Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 78. Novartis Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 79. OPKO Health Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 80. Pacific Biosciences Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 81. Quest Diagnostics Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 82. Qiagen Revenue Growth Rate in Oncology Precision Medicine Business (2016-2021)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Keyplayers in Global Oncology Precision Medicine Market Size, Status and Forecast 2021-2027
Abbott LaboratoriesAgilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen
Request Sample
Request Discount
